Justyna Piekielna

Lodz, LD, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction for "Synthesis of Mixed Opioid Affinity Cyclic Endomorphin-2 Analogues with Fluorinated Phenylalanines".

Correction for "Synthesis of Mixed Opioid Affinity Cyclic Endomorphin-2 Analogues with Fluorinated Phenylalanines".

Journal: ACS medicinal chemistry letters

Published: June 22, 2016

Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.

Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.

Journal: Biopolymers

Published: January 23, 2016

Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity.

Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity.

Journal: Organic & biomolecular chemistry

Published: May 08, 2015

Synthesis of mixed opioid affinity cyclic endomorphin-2 analogues with fluorinated phenylalanines.

Synthesis of mixed opioid affinity cyclic endomorphin-2 analogues with fluorinated phenylalanines.

Journal: ACS medicinal chemistry letters

Published: February 03, 2015

Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.

Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.

Journal: European journal of medicinal chemistry

Published: January 16, 2015

Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-D-alanine.

Cyclic side-chain-linked opioid analogs utilizing cis- and trans-4-aminocyclohexyl-D-alanine.

Journal: Bioorganic & medicinal chemistry

Published: August 12, 2014

Antinociceptive and antidepressant-like action of endomorphin-2 analogs with proline surrogates in position 2.

Antinociceptive and antidepressant-like action of endomorphin-2 analogs with proline surrogates in position 2.

Journal: Bioorganic & medicinal chemistry

Published: April 25, 2014

Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues.

Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues.

Journal: Peptides

Published: January 29, 2014

Cyclic pentapeptide analogs based on endomorphin-2 structure: cyclization studies using liquid chromatography combined with on-line mass spectrometry and tandem mass spectrometry.

Cyclic pentapeptide analogs based on endomorphin-2 structure: cyclization studies using liquid chromatography combined with on-line mass spectrometry and tandem mass spectrometry.

Journal: Peptides

Published: January 08, 2014

Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration.

Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration.

Journal: Bioorganic & medicinal chemistry letters

Published: August 06, 2013

Cyclization in opioid peptides.

Cyclization in opioid peptides.

Journal: Current drug targets

Published: March 19, 2013

Pharmacological properties of novel cyclic pentapeptides with µ-opioid receptor agonist activity.

Pharmacological properties of novel cyclic pentapeptides with µ-opioid receptor agonist activity.

Journal: Medicinal chemistry (Shariqah (United Arab Emirates))

Published: November 29, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026